Principal Investigators

    GREENAMYRE, J TIMOTHY

    Institution

    UNIVERSITY OF PITTSBURGH AT PITTSBURGH

    Contact information of lead PI

    Country

    USA

    Title of project or programme

    alpha-Synuclein Inhibition of Mitochondrial Protein Import

    Source of funding information

    NIH (NINDS)

    Total sum awarded (Euro)

    € 2,043,805.50

    Start date of award

    15/09/2015

    Total duration of award in years

    4

    The project/programme is most relevant to:

    Parkinson's disease & PD-related disorders

    Keywords

    Protein Import, alpha synuclein, Mitochondrial Proteins, Mitochondria, Outer Mitochondrial Membrane

    Research Abstract

    ? DESCRIPTION (provided by applicant): Parkinson disease (PD) is a common neurodegenerative disorder resulting in motor impairment, cognitive and psychiatric symptoms and autonomic dysfunction. Genetic and environmental factors have been implicated in PD pathogenesis, and it appears that mitochondrial defects and accumulation of the synaptic protein, ?- synuclein, are common to most forms of the disease. Moreover, there is evidence of a bidirectional interaction between mitochondrial dysfunction and ?-synuclein accumulation. Inhibition of mitochondrial complex I leads to accretion and oligomerization of ?-synuclein, and increased levels of ?-synuclein cause mitochondrial impairment and production of reactive oxygen species (ROS). The nature of the interaction between ?- synuclein and mitochondria remains obscure, and it is unclear whether unmodified monomeric ?-synuclein is responsible for these effects, or whether posttranslational modifications which have been implicated in pathogenesis, such as oligomerization, dopamine modification, phosphorylation or nitration are important. Mitochondria contain their own genome, but it encodes only 13 proteins, so they must import about 99% of the >1000 proteins they contain. Mitochondrial protein import occurs through complex and highly regulated systems, the best understood of which recognizes N-terminal mitochondrial targeting signals (MTS) on proteins destined for import. While there is no consensus sequence, MTS characteristically form an amphipathic helix that is recognized by a receptor protein, TOM20, which is a subunit of the translocase complex of the outer mitochondrial membrane (TOM). Although monomeric ?-synuclein is an intrinsically disordered protein in solution, in association with anionic lipids in membranes, it forms an amphipathic helix similar to known MTS motifs. In this context, we have strong evidence that certain forms of posttranslationally-modified ?-synuclein bind specifically to TOM20 and interfere with import of mitochondrially-targeted proteins. We propose to study the interaction of ?-synuclein with mitochondrial import machinery in the following aims: (1) Define the specific forms of ?-synuclein that inhibit mitochondrial protein import; (2) Define key binding partners and binding parameters; (3) Determine functional consequences of ?-synuclein-induced impairment of mitochondrial protein import; (4) Investigate whether blockade of mitochondrial protein import causes nigrostriatal neurodegeneration similar to ?-synuclein overexpression; and (5) Examine the potential for genetic manipulation of mitochondrial import to protect against AAV2-mediated ?-synuclein overexpression in substantia nigra.

    Lay Summary

    PUBLIC HEALTH RELEVANCE: Two key factors in the causation of Parkinson’s disease are (i) a protein called ?-synuclein and (ii) impairment of the cells’ power plants – the mitochondria. We have discovered a novel mechanism by which these 2 factors are directly related: ?-synuclein blocks a key maintenance function needed by mitochondria – protein import. This proposal seeks to better define this mechanism and to develop therapeutic strategies to combat it.

    Further information available at:

Types: Investments > €500k
Member States: United States of America
Diseases: Parkinson's disease & PD-related disorders
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF